| RA Manager |
INSURGENTES |
Mexico |
Development |
Innovative Medicines |
Research & Development |
Rug 03, 2024 |
| Clinical Research Medical Advisor |
Barcelona Gran Vía |
Spain |
Development |
Innovative Medicines |
Research & Development |
Rug 06, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Feasibility Manager |
INSURGENTES |
Mexico |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Patient Safety Manager |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Development |
Innovative Medicines |
Research & Development |
Rug 04, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Head, Clinical Development Business Solutions |
Basel (City) |
Switzerland |
Development |
Innovative Medicines |
Research & Development |
Spa 10, 2024 |
| Central Integrated Scientific Review Committee Lead |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
Spa 14, 2024 |
| Associate Director, Clinical Processes & Solutions |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Development |
Innovative Medicines |
Research & Development |
Spa 14, 2024 |
| Head Clinical Development Business Solutions |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
Spa 18, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Clinical Research Associate |
Field Force (Italy) |
Italy |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Clinical Biospecimen Senior Scientist |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Rug 03, 2024 |
| Senior Statistical Programmer |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Lie 18, 2024 |
| Study Leader |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Rug 05, 2024 |
| Head Regulatory Writing |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 07, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Japan Program Head (Neuroscience & GTx) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Japan Program Head (Immunology) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Manager, TRD Project management |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 16, 2024 |
| Associate Clinical Project Manager |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Spa 18, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Expert Science & Technology |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Research & Development |
Rug 03, 2024 |
| Regulatory Affairs Manager |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Rug 01, 2024 |
| Clinical Research Associate |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Spa 09, 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Rugp 22, 2024 |
| Associate Director, Data Privacy, Digital & AI |
East Hanover |
USA |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Rug 04, 2024 |
| Manager- Data Privacy Review and Remediation |
Telangana |
India |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Spa 10, 2024 |
| Associate Director - Risk & Assurance, EUROPE |
Prague |
Czech Republic |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Spa 11, 2024 |
| Sr Manager/Manager-Monitoring |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Lie 18, 2024 |
| Head DPDAI China |
Shanghai (Shanghai) |
China |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Spa 14, 2024 |
| Associate Director ERC Risk&Operations, Corporate Functions |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Rugp 29, 2024 |
| Manager- Data Privacy Review and Remediation |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Corporate |
Legal & Intellectual Property & Compl. |
Spa 14, 2024 |
| Risk & Assurance Manager |
Mumbai (Head Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Spa 16, 2024 |
| Country ERC Head, India |
Mumbai (Office) |
India |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compl. |
Spa 16, 2024 |
| Financial Accounting Specialist (m/w/d) |
Schaftenau |
Austria |
Finance |
CTS |
Audit & Finance |
Rug 13, 2024 |
| Commercial & Medical Excellence Manager (f/m/d) |
Vienna |
Austria |
Finance |
Innovative Medicines |
Data and Digital |
Spa 15, 2024 |
| ERP Assurance Senior Consultant-2 |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Rugp 20, 2024 |
| Business Planning and Analysis Manager, Novartis Technical Operations |
INSURGENTES |
Mexico |
Finance |
Innovative Medicines |
Audit & Finance |
Rugp 22, 2024 |
| Investor Relations Executive Director |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Rugp 28, 2024 |
| Tax Manager m/w/d) |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
Finance |
Corporate |
Audit & Finance |
Spa 16, 2024 |
| RLT Sasayama_Associate_Finance Business Planning and Analysis |
Sasayama |
Japan |
Finance |
Innovative Medicines |
Audit & Finance |
Rug 17, 2024 |
| Senior Manager ERP Assurance |
Hyderabad (Office) |
India |
Finance |
CTS |
Audit & Finance |
Rug 23, 2024 |
| R2R Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Lie 28, 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
Rugp 05, 2024 |
| S2P Business Partner (Korean speaker) |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Rug 24, 2024 |
| Senior FRA Specialist GL |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
Rug 26, 2024 |